The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat).
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17003701.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe two innovative ideas in the treatment of iatrogenic chyle leak. The first is the early use of a pancreatic lipase inhibitor (Orlistat) to reduce fat absorption and chyle production, with consequent faster fistula healing. The second is the treatment of these patients at home in the community by district nurses backed by the hospital staff. This domiciliary approach has a positive psychological effect on the patient, permits the patient to take responsibility for their treatment, and reduces hospital length of stay minimising patient exposure to nosocomial infections.
Medical subject headings
- Chyle
- Enzyme Inhibitors
- Fistula
- Home Care Services
- Lactones
- Lipase
- Lymphatic Diseases
- Thoracic Duct